These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37365785)

  • 1. Virtual Screening of Flavonoids against
    Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
    Curr Comput Aided Drug Des; 2024; 20(5):616-627. PubMed ID: 37365785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational Exploration of Licorice for Lead Compounds against
    Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110591
    [No Abstract]   [Full Text] [Related]  

  • 3. Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARC.
    Batchelor JD; Malpede BM; Omattage NS; DeKoster GT; Henzler-Wildman KA; Tolia NH
    PLoS Pathog; 2014 Jan; 10(1):e1003869. PubMed ID: 24415938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Erythrocyte Binding Protein of Plasmodium vivax Suggests an Alternate Invasion Pathway into Duffy-Positive Reticulocytes.
    Ntumngia FB; Thomson-Luque R; Torres Lde M; Gunalan K; Carvalho LH; Adams JH
    mBio; 2016 Aug; 7(4):. PubMed ID: 27555313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence similarity between the erythrocyte binding domain of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals a functional heparin binding motif involved in binding to the Duffy antigen receptor for chemokines.
    Bolton MJ; Garry RF
    Virol J; 2011 Nov; 8():523. PubMed ID: 22122911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.
    Siyah P; Akgol S; Durdagi S; Kocabas F
    Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence similarity between the erythrocyte binding domain 1 of the Plasmodium vivax Duffy binding protein and the V3 loop of HIV-1 strain MN reveals binding residues for the Duffy Antigen Receptor for Chemokines.
    Bolton MJ; Garry RF
    Virol J; 2011 Jan; 8():45. PubMed ID: 21281498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphated tyrosines mediate association of chemokines and Plasmodium vivax Duffy binding protein with the Duffy antigen/receptor for chemokines (DARC).
    Choe H; Moore MJ; Owens CM; Wright PL; Vasilieva N; Li W; Singh AP; Shakri R; Chitnis CE; Farzan M
    Mol Microbiol; 2005 Mar; 55(5):1413-22. PubMed ID: 15720550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium simium, a Plasmodium vivax-related malaria parasite: genetic variability of Duffy binding protein II and the Duffy antigen/receptor for chemokines.
    Camargos Costa D; Pereira de Assis GM; de Souza Silva FA; Araújo FC; de Souza Junior JC; Braga Hirano ZM; Satiko Kano F; Nóbrega de Sousa T; Carvalho LH; Ferreira Alves de Brito C
    PLoS One; 2015; 10(6):e0131339. PubMed ID: 26107662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study.
    Boateng RA; Tastan Bishop Ö; Musyoka TM
    Malar J; 2020 Nov; 19(1):442. PubMed ID: 33256744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling.
    Yadav MK; Singh A; Swati D
    Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes.
    Chitnis CE; Chaudhuri A; Horuk R; Pogo AO; Miller LH
    J Exp Med; 1996 Oct; 184(4):1531-6. PubMed ID: 8879225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Plasmodium vivax Duffy-binding protein.
    Chitnis CE; Sharma A
    Trends Parasitol; 2008 Jan; 24(1):29-34. PubMed ID: 18023618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC.
    Batchelor JD; Zahm JA; Tolia NH
    Nat Struct Mol Biol; 2011 Jul; 18(8):908-14. PubMed ID: 21743458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.
    Singh S; Pandey K; Chattopadhayay R; Yazdani SS; Lynn A; Bharadwaj A; Ranjan A; Chitnis C
    J Biol Chem; 2001 May; 276(20):17111-6. PubMed ID: 11279211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition.
    VanBuskirk KM; Sevova E; Adams JH
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15754-9. PubMed ID: 15498870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The domain on the mouse Duffy protein for Plasmodium yoelii binding and invasion to mouse erythrocytes.
    Xu L; Niu J; Chaudhuri A
    Mol Biochem Parasitol; 2006 Apr; 146(2):142-50. PubMed ID: 16386320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in Thailand.
    Chootong P; Panichakul T; Permmongkol C; Barnes SJ; Udomsangpetch R; Adams JH
    PLoS One; 2012; 7(4):e35769. PubMed ID: 22558221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins.
    Ranjan A; Chitnis CE
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14067-72. PubMed ID: 10570199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.